Avigen is investigating the use of AAV vectors to deliver the factor IX gene for the treatment of hemophilia B and the factor VIII gene for hemophilia A. Preclinical efficacy and safety studies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback